Concepedia

Phillip Liu

PL

Statistics

Publications

14

Citations

1.7K

H-Index

14

Active since

1985

Affiliations

Incyte (United States)(Current)

The University of Texas MD Anderson Cancer Center

Experimental Station

Fred Hutch Cancer Center

Phillip Liu is an author at Incyte (United States) specializing in pharmacology, medicine, and life sciences.

Publications per year

1985–2024

14

Publications

14

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 827 citations

Medicine, Hematology, Pharmacology +11

Rhesus expression in a green alga is regulated by CO <sub>2</sub>

Eric Soupène, Natalie D. King, Eithne Feild et al. · Proceedings of the National Academy of Sciences · 2002 · 144 citations · Full text

Life Sciences, Biology, Plant Biology +15

The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy

Qiang Zhang, Yan Zhang, Sharon Diamond et al. · Drug Metabolism and Disposition · 2014 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +14

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer

Andrew J. Wilson, Matthew C. Stubbs, Phillip Liu et al. · Gynecologic Oncology · 2018 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics

Andrew P. Combs, Eddy W. Yue, Michael J. Bower et al. · Journal of Medicinal Chemistry · 2005 · 102 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 14